Transcription_NN
factors_NNS
as_IN
targets_NNS
for_IN
oxidative_JJ
signalling_NN
during_IN
lymphocyte_NN
activation_NN
._.

We_PRP
previously_RB
have_VBP
demonstrated_VBN
a_DT
requirement_NN
for_IN
oxidative_JJ
events_NNS
during_IN
cell_NN
cycle_NN
entry_NN
in_IN
T_NN
lymphocytes_NNS
and_CC
have_VBP
hypothesised_VBN
that_IN
reactive_JJ
oxygen_NN
species_NNS
may_MD
act_VB
as_IN
intracellular_JJ
signalling_NN
agents_NNS
during_IN
lymphocyte_NN
activation_NN
._.

In_IN
the_DT
current_JJ
study_NN
,_,
cysteamine_NN
,_,
an_DT
aminothiol_NN
compound_NN
with_IN
antioxidant_JJ
activity_NN
,_,
has_VBZ
been_VBN
used_VBN
to_TO
further_RB
investigate_VB
the_DT
role_NN
of_IN
oxidative_JJ
signalling_NN
during_IN
lymphocyte_NN
activation_NN
._.

Treatment_NN
of_IN
normal_JJ
human_JJ
peripheral_JJ
blood_NN
lymphocytes_NNS
with_IN
cysteamine_NN
in_FW
vitro_FW
was_VBD
found_VBN
to_TO
inhibit_VB
proliferation_NN
in_IN
a_DT
dose-dependent_JJ
manner_NN
,_,
with_IN
essentially_RB
complete_JJ
inhibition_NN
occurring_VBG
at_IN
a_DT
dose_NN
of_IN
400_CD
microM_NN
._.

This_DT
inhibitory_JJ
effect_NN
was_VBD
limited_JJ
to_TO
the_DT
first_JJ
2_CD
h_NN
after_IN
mitogenic_JJ
activation_NN
,_,
localizing_VBG
the_DT
time-frame_NN
of_IN
action_NN
of_IN
cysteamine_NN
to_TO
within_IN
the_DT
commitment_NN
period_NN
._.

It_PRP
therefore_RB
was_VBD
of_IN
interest_NN
to_TO
establish_VB
which_WDT
,_,
if_IN
any_DT
,_,
commitment_NN
events_NNS
were_VBD
affected_VBN
by_IN
oxidative_JJ
signalling_NN
during_IN
cell_NN
cycle_NN
entry_NN
._.

Taking_VBG
the_DT
IL-2_NN
gene_NN
as_IN
a_DT
candidate_NN
,_,
we_PRP
examined_VBD
the_DT
effect_NN
of_IN
cysteamine_NN
treatment_NN
on_IN
early_JJ
gene_NN
expression_NN
during_IN
lymphocyte_NN
activation_NN
,_,
and_CC
on_IN
the_DT
activity_NN
of_IN
transcription_NN
factors_NNS
AP-1_NN
,_,
NF-kappa_NN
B_NN
,_,
NF-AT_NN
and_CC
Oct1_NN
,_,
whose_WP$
functions_NNS
are_VBP
required_VBN
for_IN
expression_NN
of_IN
the_DT
IL-2_NN
mRNA_NN
._.

Cysteamine_NN
treatment_NN
inhibited_VBD
both_CC
expression_NN
of_IN
the_DT
IL-2_NN
mRNA_NN
and_CC
secretion_NN
of_IN
IL-2_NN
into_IN
the_DT
culture_NN
medium_NN
._.

The_DT
inhibitory_JJ
effect_NN
of_IN
cysteamine_NN
may_MD
be_VB
mediated_VBN
at_IN
least_JJS
in_IN
part_NN
by_IN
an_DT
effect_NN
on_IN
transcription_NN
factor_NN
function_NN
,_,
as_IN
the_DT
DNA_NN
binding_NN
activities_NNS
of_IN
AP-1_NN
and_CC
NF-kappa_NN
B_NN
extracted_VBN
from_IN
mitogen-stimulated_JJ
cells_NNS
were_VBD
significantly_RB
inhibited_VBN
by_IN
cysteamine_NN
treatment_NN
._.

Interestingly_RB
,_,
Oct1_NN
and_CC
NF-AT_NN
DNA_NN
binding_NN
activity_NN
were_VBD
not_RB
affected_VBN
by_IN
cysteamine_NN
treatment_NN
,_,
suggesting_VBG
that_IN
oxidative_JJ
signalling_NN
processes_NNS
operate_VBP
in_IN
a_DT
selective_JJ
manner_NN
._.

The_DT
identification_NN
of_IN
regulatory_JJ
proteins_NNS
,_,
such_JJ
as_IN
transcription_NN
factors_NNS
,_,
as_IN
molecular_JJ
targets_NNS
for_IN
oxidative_JJ
signalling_NN
provides_VBZ
further_JJ
evidence_NN
to_TO
implicate_VB
oxidative_JJ
signalling_NN
as_IN
being_VBG
intimately_RB
involved_VBN
in_IN
the_DT
G0_NN
to_TO
G1_NN
phase_NN
transition_NN
in_IN
T_NN
lymphocytes_NNS
._.

